arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Heartflow, Inc.

HTFL
$28.80 ▲ +1.61 (+5.94%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
4 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

Heartflow, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.1B
Dividend Yield
Revenue Growth 39.9%
Op. Margin -36.4%
ROIC -21.3%
FCF / Share $-1.60
Trailing P/E
Price / Book 8.2x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

4-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$176.03M
↑ +39.9%
Net Income Profit after all expenses
$-116.79M
↓ -21.1%
Operating Margin Operating profit as % of sales
-36.4%
↑ +25.2% 7th
FCF / Share Free cash flow per share
$-1.60
↑ +88.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
6
Returns
20
Financial Health
33
Cash Quality
40

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 11 quarters